Sarah Read
Ophthalmology · Aiea, HINPI 1124381652
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 38.3% of the total. Reporting peaked in 2020 at $9,100 and has fallen 96.0% since, to $362 in 2025. Among ophthalmology clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $439.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$9K
- Genentech USA, Inc.$6K
- Genentech, Inc.$6K
- Alcon$609
- Sight Sciences, Inc.$419
- Regeneron Healthcare Solutions, Inc.$295
- plus $1K from 9 others
Across 20 payments — averaging $7262.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$145K
What the payments were for
- Consulting fees$9,94042%
- Speaking & faculty fees$9,10038%
- Travel & lodging$1,3076%
- Food & beverage$3,40414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 2 | $9,100 |
| Genentech USA, Inc. | 18 | $6,332 |
| Genentech, Inc. | 7 | $5,727 |
| Alcon | 7 | $609 |
| Sight Sciences, Inc. | 3 | $419 |
| Regeneron Healthcare Solutions, Inc. | 4 | $295 |
| Aerie Pharmaceuticals, Inc. | 2 | $216 |
| Astellas Pharma US Inc | 2 | $203 |
| Glaukos Corporation | 1 | $178 |
| Hoffmann-la Roche Limited | 2 | $163 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $134 |
| Astellas Pharma Global Development | 1 | $133 |
| Novartis | 1 | $106 |
| Amgen | 1 | $89 |
| Apellis Pharmaceuticals, Inc. | 1 | $46 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lucentis$9,626
- CIRRUS HD-OCT$9,100
- CLARUS$9,100
- OMNI(R) SURGICAL SYSTEM (US)$419
- Rocklatan$337
- VABYSMO$295
- Izervay$255
- Rhopressa$229
- LenSx$147
- ARGOS$146
- Constellation$142
- EYLEA HD$125
- EYLEA$116
How this compares
$23,751 in reported general payments places this provider in the 90th percentile of 120 ophthalmology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 50 | $9,010 |
| ProlensaBromfenac Sodium | 19 | $6,866 |
| Prednisolone Acetate | 50 | $3,035 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 109 | $1,311 |
| Brimonidine Tartrate | 13 | $942 |
| Atropine Sulfate | 16 | $815 |
| MoxifloxacinMoxifloxacin Hcl | 13 | $457 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 32 | $379 |
| Latanoprost | 12 | $212 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $155 |
| Diclofenac Sodium | 11 | $123 |
| Timolol Maleate | 15 | $104 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Aiea
- Gregg KokameAiea$73K
- William WongAiea$40K
- Luis OmphroyAiea$25K
- Raymond WeeAiea$7K
- James LaiAiea$6K
- Kenneth LeeAiea$3K
- Neda NikpoorHonolulu$293K
- Carlton YuenHonolulu$175K
- Alan FaulknerHonolulu$135K
- Michael BennettHonolulu$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.